相关实验视频
Updated: May 29, 2025

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
18.6K
糖尿病酸症住院成人的持续葡萄糖监测:一个前性的开放标签试点研究
Magdalena M Bogun1, Chunhui Wang2, Paul A Kurlansky2
1Department of Medicine, Columbia University, New York, NY, USA.
Journal of diabetes science and technology
|February 5, 2025
概括
持续的葡萄糖监测 (CGM) 是有效的管理糖尿病酸症 (DKA) 在住院成年人. 这项试点研究发现,在胰岛素治疗期间和DKA解决后,CGM可靠,支持其在急性护理环境中的使用.
科学领域:
- 内分泌学 在内分泌学.
- 医疗器械 医疗器械
- 糖尿病管理 糖尿病管理
背景情况:
- 持续血糖监测 (CGM) 在医院环境中越来越多地被采用.
- 对于患有糖尿病酸症 (DKA) 的成年人来说,CGM的有效性仍然未确立.
研究的目的:
- 评估实时CGM在评估DKA的成年人血糖控制中的有效性.
- 为了比较CGM性能与毛细血管点护理 (POC) 和基本代谢面板 (BMP) 葡萄糖测量.
主要方法:
- 一个单一中心的试点研究涉及52名患有DKA (1型和2型糖尿病) 的成年患者.
- 实时CGM (Dexcom G6) 与静脉注射胰岛素治疗期间的POC和BMP葡萄糖值的比较以及DKA后的解析.
- 分析包括平均绝对相对差异 (MARD),中位数绝对相对差异 (ARD) 和糖尿病技术协会 (DTS) 错误网格分析.
主要成果:
- 在IV胰岛素治疗期间,CGM显示了与POC测试相比,平均绝对相对差异 (MARD) 为17.4%.
- 糖尿病技术协会 (DTS) 错误网分析显示,在IV胰岛素治疗期间,A+B区的CGM值达到100%.
- 在DKA解决后,CGM的性能仍然可靠,MARD值与POC和BMP测量值相比.
结论:
- 实时CGM是监测患有DKA的住院成年人血糖控制的可靠工具.
- 在急性胰岛素治疗期间和DKA解决后,CGM可以有效地使用.
- 需要进一步的多中心随机试验来证实CGM在高血糖危机管理中的好处.
相关概念视频
Hypoglycemia and Glucagon
149
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
149
Diabetes: Symptoms, Diagnosis, and Complications
499
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
499
Diabetes Mellitus: Type 2 and Gestational
2.1K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.1K
Glucose Homeostasis: Regulation of Blood Glucose
1.4K
Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
1.4K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
1.1K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
1.1K
Diabetes: Management and Pharmacotherapy
232
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
232

